Ventas, Inc. (VTR) EPS CAGR:175.19%(TTM)
EPS CAGR uses precomputed diluted earnings history where available.
Over longer horizons, Ventas, Inc.'s EPS CAGR averages 43.42% over 3 years and -14.16% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. EPS (Earnings Per Share) CAGR measures how Ventas, Inc.'s earnings per share have grown. This is a key metric for valuation and reflects profitability on a per-share basis.
VTR EPS CAGR Chart
Ventas, Inc. (VTR)
VTR Quarterly EPS Growth (YoY)
EPS growth vs the same quarter one year earlier, last 20 quarters.
VTR EPS CAGR History
| Year | Start EPS | End EPS | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $0.20 | $0.55 | +$0.35 | +175.00% | +175.00% |
| 2024 | $-0.10 | $0.20 | +$0.30 | N/A | N/A |
| 2023 | $-0.13 | $-0.10 | +$0.03 | N/A | N/A |
| 2022 | $0.13 | $-0.13 | $-0.26 | -200.00% | N/A |
| 2021 | $1.18 | $0.13 | $-1.05 | -88.98% | -88.98% |
| 2020 | $1.18 | $1.18 | +$0.00 | +0.00% | +0.00% |
| 2019 | $1.15 | $1.18 | +$0.03 | +2.61% | +2.61% |
| 2018 | $3.82 | $1.15 | $-2.67 | -69.90% | -69.90% |
| 2017 | $1.88 | $3.82 | +$1.94 | +103.19% | +103.19% |
| 2016 | $1.26 | $1.88 | +$0.62 | +49.21% | +49.21% |
| 2015 | $1.62 | $1.26 | $-0.36 | -22.22% | -22.22% |
| 2014 | $1.55 | $1.62 | +$0.07 | +4.52% | +4.52% |
| 2013 | $1.24 | $1.55 | +$0.31 | +25.00% | +25.00% |
| 2012 | $1.60 | $1.24 | $-0.36 | -22.50% | -22.50% |
| 2011 | $1.57 | $1.60 | +$0.03 | +1.91% | +1.91% |
| 2010 | $1.75 | $1.57 | $-0.18 | -10.29% | -10.29% |
| 2009 | $1.62 | $1.75 | +$0.13 | +8.02% | +8.02% |
| 2008 | $2.26 | $1.62 | $-0.64 | -28.32% | -28.32% |
| 2007 | $1.26 | $2.26 | +$1.00 | +79.37% | +79.37% |
| 2006 | $1.37 | $1.26 | $-0.11 | -8.03% | -8.03% |
| 2005 | $1.45 | $1.37 | $-0.08 | -5.52% | -5.52% |
| 2004 | $2.05 | $1.45 | $-0.60 | -29.27% | -29.27% |
| 2003 | $0.95 | $2.05 | +$1.10 | +115.79% | +115.79% |
| 2002 | $0.74 | $0.95 | +$0.21 | +28.38% | +28.38% |
| 2001 | $-0.96 | $0.74 | +$1.70 | N/A | N/A |
| 2000 | $0.63 | $-0.96 | $-1.59 | -252.38% | N/A |
| 1999 | $0.39 | $0.63 | +$0.24 | +61.54% | +61.54% |
| 1998 | $1.90 | $0.39 | $-1.51 | -79.47% | -79.47% |
| 1997 | $0.68 | $1.90 | +$1.22 | +179.41% | +179.41% |
Quarterly EPS: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $0.12 | -20.0% | +9.1% |
| Q4 2025 | $0.15 | +7.1% | +15.4% |
| Q3 2025 | $0.14 | -6.7% | +201.7% |
| Q2 2025 | $0.15 | +36.4% | +215.8% |
| Q1 2025 | $0.11 | -15.4% | — |
| Q4 2024 | $0.13 | +180.2% | — |
| Q3 2024 | $0.05 | -2.3% | — |
| Q2 2024 | $0.05 | — | -81.7% |
| Q1 2024 | $-0.04 | +84.6% | — |
| Q4 2023 | $-0.23 | -27.8% | -109.1% |
| Q3 2023 | $-0.18 | — | — |
| Q2 2023 | $0.26 | +493.6% | — |
| Q1 2023 | $0.04 | — | -54.8% |
| Q4 2022 | $-0.11 | — | -12.2% |
| Q3 2022 | $0.01 | — | -95.2% |
| Q2 2022 | $-0.11 | — | — |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Ventas, Inc.
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- CEO
- Debra A. Cafaro